Versant Venture Capital VI, L.P.

person

Unified public record assembled from the source systems listed below. Amounts describe distinct reported activity and are not added into a single influence total.

Political giving

—

Political receipts

—

Lobbying income

—

Lobbying expense

—

Federal awards

—

Relationships

Connected records

Relationship	Connected entity	Amount / weight	Period
insider of	Akero Therapeutics, Inc.	26,481,962.66	Jun 24, 2019 – Dec 31, 2019

Source coverage

sec insider: 0001687880

Versant Venture Capital VI, L.P. — Influence Profile | Poliscope